GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Treatment com AI Inc (XCNQ:TRUE) » Definitions » YoY EBITDA Growth

Treatment com AI (XCNQ:TRUE) YoY EBITDA Growth : -2.22% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Treatment com AI YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Treatment com AI's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was -2.22%.

Treatment com AI's EBITDA per Share for the three months ended in Dec. 2024 was C$-0.05.


Treatment com AI YoY EBITDA Growth Historical Data

The historical data trend for Treatment com AI's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Treatment com AI YoY EBITDA Growth Chart

Treatment com AI Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial -332.38 -370.93 71.75 57.95 31.89

Treatment com AI Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 55.88 56.36 -65.85 89.43 -2.22

Treatment com AI YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Treatment com AI's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(-0.173--0.254)/ | -0.254 |
=31.89 %

Treatment com AI's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(-0.046--0.045)/ | -0.045 |
=-2.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Treatment com AI YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Treatment com AI's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Treatment com AI Business Description

Traded in Other Exchanges
Address
838 West Hastings Street, Suite 700, Vancouver, BC, CAN, V6C 0A6
Treatment com AI Inc operates in the business of providing personalized health care information that is relevant and trustworthy empowering patients to make responsible, informed decisions about their health while improving communications, reducing costs and in-clinic wait times for medical practitioners.
Executives
Essam Hamza Director, Senior Officer